Suzanne Christie, MD, FRCPC

A Bit About Me

Dr. Suzanne Christie's research focuses on improving outcomes for patients with chronic migraine and cluster headache through real-world studies and evidence-based treatment evaluations. She has contributed to key studies demonstrating the effectiveness of onabotulinumtoxinA in reducing migraine frequency, improving quality of life, and decreasing healthcare resource use. Additionally, she has played a leading role in comparative effectiveness research and guideline development to inform best practices in headache management across Canada